Akathisia is a distressing movement-related condition in which a person feels driven to move and finds it difficult, sometimes nearly impossible, to remain still. It is most often linked to medications that affect dopamine signaling, especially antipsychotic medicines, but it can also appear with other drugs or during medication changes.
The condition can be hard to recognize because it may look like anxiety, agitation, panic, insomnia, worsening psychiatric symptoms, or “just restlessness.” That confusion matters. Akathisia can cause intense inner distress, interfere with sleep and daily functioning, and, in severe cases, become associated with impulsive behavior or suicidal thoughts. Understanding the difference between ordinary nervous energy and akathisia can help people describe symptoms more clearly and seek timely professional evaluation.
Table of Contents
- What Akathisia Means
- Akathisia Symptoms and Signs
- Types and Time Course
- Causes and Medication Triggers
- Risk Factors for Akathisia
- Conditions That Can Look Similar
- Diagnostic Context and Rating Scales
- Complications and Urgent Evaluation
What Akathisia Means
Akathisia is best understood as a combination of inner restlessness and observable motor restlessness. The person does not merely prefer to move; they often feel an uncomfortable pressure, unease, or agitation that movement temporarily relieves but does not fully settle.
The word is often used in psychiatric and neurological settings because akathisia belongs to a group of medication-induced movement disorders sometimes called extrapyramidal symptoms. These movement effects are especially associated with medicines that block dopamine receptors, although dopamine is not the only chemical system involved. Akathisia is not the same as anxiety, but anxiety-like distress can be part of the experience.
A key feature is the mismatch between how the symptom looks from the outside and how it feels from the inside. A person may appear impatient, irritable, restless, or unable to cooperate. Internally, they may feel trapped in their body, unable to get comfortable, or desperate to keep moving. Some describe it as “crawling out of my skin,” “electric restlessness,” “inner torture,” or “a pressure that makes me pace.”
Akathisia can occur in people being treated for schizophrenia, bipolar disorder, major depression, nausea, migraine, gastrointestinal symptoms, or other conditions involving dopamine-blocking drugs. It can also be relevant when new symptoms appear after a medication is started, stopped, increased, decreased, or combined with another drug.
The condition is clinically important because it can be missed. If the restlessness is assumed to be worsening psychosis, mania, anxiety, or behavioral agitation, the underlying cause may not be recognized. In some cases, that can lead to more distress and more difficulty describing what is happening.
Akathisia can vary from mild to severe. Mild cases may involve fidgeting, leg movement, and discomfort when sitting through meetings or meals. Severe cases can make sleep, conversation, work, travel, and basic rest almost impossible. The level of distress is often more important than the amount of movement seen by others.
Akathisia Symptoms and Signs
The central symptom of akathisia is an uncomfortable need to move, usually paired with mental unease. The signs may be obvious, subtle, or mostly reported by the person experiencing them.
The subjective symptoms are often the most important clues. These may include:
- A strong urge to pace, rock, shift position, or keep the legs moving
- Inner tension, unease, dread, irritability, or dysphoria
- A feeling of being unable to relax, sit through a conversation, or stay in bed
- Distress that worsens when expected to remain still
- Temporary relief while walking, rocking, or changing position
- Trouble sleeping because stillness feels intolerable
- A sense of panic or desperation that does not feel like ordinary worry
Observable signs often involve repetitive movement rather than random activity. Common examples include pacing, marching in place, rocking from foot to foot, repeatedly crossing and uncrossing the legs, shifting weight while standing, rubbing the thighs, swinging the legs while seated, or repeatedly getting up from a chair.
| Feature | How it may feel or look | Why it matters |
|---|---|---|
| Inner restlessness | Intense unease, tension, or urge to move | May be mistaken for anxiety or agitation |
| Motor restlessness | Pacing, rocking, shifting, leg movement | Provides visible clues during assessment |
| Distress | Fear, irritability, dysphoria, inability to settle | Helps distinguish akathisia from harmless fidgeting |
| Timing | Often follows a medication start, dose increase, or drug change | Can point toward a medication-induced movement disorder |
Akathisia can be especially confusing when the person uses anxiety language to describe it. They may say they feel “nervous,” “panicky,” “wired,” or “agitated,” even when the problem is not mainly fear-based. That overlap is one reason clinicians ask about both emotional symptoms and body movement. A person with anxiety symptoms may feel restless because of worry or threat sensitivity, while a person with akathisia may feel restless because stillness itself feels physically intolerable.
The lower body is often prominent. Many people describe restlessness in the legs, hips, or trunk, although the whole body can feel affected. The person may be able to suppress the movement briefly, especially in formal settings, but doing so may increase inner distress.
Some people have mainly subjective akathisia, where the inner discomfort is strong but visible movement is limited. Others may show visible movement but report less distress, a pattern sometimes called pseudoakathisia in clinical discussions. These distinctions can matter during assessment, but for the person affected, the most important point is whether the restlessness is new, intense, impairing, and linked in time to medication exposure or another medical change.
Types and Time Course
Akathisia is often classified by when it appears and how long it lasts. The timing can help separate medication-induced akathisia from other causes of restlessness.
Acute akathisia usually appears soon after a triggering medication is started or increased. In many cases, symptoms begin within days to a few weeks. This is the pattern most clinicians think of first when someone develops new pacing, leg movement, or severe internal unease after an antipsychotic or another dopamine-blocking medicine.
Subacute or chronic akathisia refers to symptoms that continue longer. The exact cutoffs vary across sources, but the practical issue is persistence: the person remains restless and distressed beyond the early adjustment period. Chronic symptoms can become exhausting because the person may have weeks or months of poor sleep, difficulty sitting, and repeated attempts to explain symptoms that others misread.
Tardive akathisia is a delayed form that appears after longer exposure to a dopamine receptor blocking drug or after a change in that exposure. It belongs conceptually near other tardive syndromes, such as tardive dyskinesia, because the onset can be delayed and the course may be more prolonged. Tardive akathisia can be harder to connect to a medication because the trigger may not be recent.
Withdrawal or discontinuation-related akathisia can occur after reducing or stopping some medicines, especially when the nervous system has adapted to long-term exposure. The word “withdrawal” can be misleading if it suggests addiction; in many medical contexts, it simply means symptoms that emerge when a medication is changed or removed. This is one reason a careful timeline matters.
The time course is not always neat. A person may have mild restlessness after a dose increase, feel worse after another medication is added, and then experience persistent symptoms that no longer fit a simple early-onset pattern. Sleep loss, pain, substance use, medical illness, and psychiatric symptoms can all blur the picture.
For practical understanding, the most useful questions are:
- When did the restlessness begin?
- What medication or dose changes happened before it started?
- Is the restlessness mainly internal, visible, or both?
- Does movement temporarily reduce the discomfort?
- Is there new distress, impulsivity, insomnia, or suicidal thinking?
These questions do not diagnose the condition by themselves, but they help create the timeline a clinician needs.
Causes and Medication Triggers
Akathisia is most commonly associated with medications that affect dopamine signaling, especially antipsychotic medicines. It can also occur with other prescription drugs, medication changes, and some substances.
The best-known trigger is antipsychotic medication. This includes older first-generation antipsychotics and newer second-generation antipsychotics. Higher-potency dopamine-blocking drugs have traditionally been associated with greater risk, but newer antipsychotics can still cause akathisia in some people. Risk varies by drug, dose, speed of dose changes, individual vulnerability, and the clinical situation.
Akathisia can also occur with dopamine-blocking anti-nausea medicines, such as metoclopramide and prochlorperazine. These medicines may be used outside psychiatric care, so people may not expect a movement-related side effect. A person treated in an emergency department, migraine clinic, primary care setting, or gastrointestinal setting may develop restlessness and not connect it to an antiemetic.
Some antidepressants, including selective serotonin reuptake inhibitors and related drugs, have been linked to akathisia-like restlessness in a minority of people. This can be difficult to distinguish from early activation, anxiety, insomnia, or agitation during antidepressant initiation. A separate discussion of SSRI startup side effects may help explain why early medication changes can feel different from the symptoms the medicine is intended to treat.
Other reported triggers or contributors can include certain calcium channel blockers, sedatives used around procedures, drugs affecting dopamine in Parkinson’s disease, lithium, stimulants, cocaine, and medication withdrawal states. Not every restless reaction after these exposures is akathisia, but the timing should prompt careful review.
The underlying biology is not fully settled. Dopamine blockade in movement-related brain circuits is a major part of the explanation, but akathisia likely involves broader interaction among dopamine, serotonin, acetylcholine, norepinephrine, and brain regions involved in movement, reward, distress, and arousal. This may explain why akathisia feels both physical and psychological.
It is also important to separate cause from context. A person may have psychosis, bipolar disorder, depression, nausea, or migraine and still have akathisia caused by a medicine used in that context. The presence of a psychiatric diagnosis does not mean new restlessness is automatically psychological. Likewise, a medication exposure does not prove akathisia; the symptoms, timing, and differential diagnosis still matter.
Risk Factors for Akathisia
Several factors can make akathisia more likely, although no single factor predicts it with certainty. The highest-yield clues are medication type, dose pattern, recent medication changes, and prior sensitivity to movement side effects.
Medication-related risk factors include starting a dopamine-blocking drug, increasing the dose quickly, using higher doses, combining medications that increase side-effect burden, or using a drug with a stronger tendency to affect dopamine pathways. First exposure can be important. People who have not previously taken antipsychotics may be more sensitive to early movement-related adverse effects.
Personal risk factors are less predictable but may include younger age, a previous history of akathisia or other extrapyramidal symptoms, neurological vulnerability, and certain psychiatric contexts such as acute psychosis or mood episodes. Some studies have suggested sex- or subgroup-specific associations, but the evidence is not simple enough to use as a reliable individual prediction tool.
Clinical setting matters. A person in an emergency, inpatient, or acute psychiatric setting may receive medication changes quickly because symptoms are severe. That same setting can make akathisia harder to identify, because pacing, agitation, fear, insomnia, or inability to sit still may be attributed to the underlying crisis. In first-episode psychosis evaluations, for example, new movement symptoms after antipsychotic exposure need careful interpretation alongside the psychiatric symptoms being assessed. A broader first-episode psychosis evaluation often considers medication effects, substance use, medical illness, and symptom course together.
Medical and substance-related factors can also complicate risk. Dehydration, severe insomnia, stimulant use, alcohol or sedative withdrawal, pain, delirium, and metabolic problems can all produce agitation or restlessness. These may not cause akathisia directly, but they can make the presentation harder to read or intensify distress.
A prior episode is especially important. Someone who has had akathisia before may recognize the feeling quickly, often before visible signs are obvious to others. That history should be taken seriously, because the subjective experience is a major part of the syndrome.
Risk is not limited to psychiatric care. People taking dopamine-blocking antiemetics for nausea, migraine, gastroparesis, or vertigo may also be affected. Because these medicines may be prescribed short term, symptoms may appear suddenly and be misread as panic, pain behavior, or worsening nausea-related distress.
Conditions That Can Look Similar
Akathisia is often mistaken for other conditions because restlessness is a common human symptom. The distinction depends on the quality of the restlessness, the timing, the medication history, and the presence of other physical or mental signs.
Anxiety can cause pacing, trembling, muscle tension, and difficulty sitting still. Panic can produce a sudden surge of fear, chest tightness, shortness of breath, dizziness, and a sense of impending danger. Akathisia may feel panicky, but it is usually centered on an unbearable need to move rather than a fear-based episode. When symptoms resemble panic attacks, the timeline around medication changes becomes especially important.
Agitated depression can include inner torment, irritability, insomnia, and purposeless movement. Mania can involve high energy, pressured speech, reduced need for sleep, impulsivity, and increased goal-directed activity. Akathisia can coexist with mood symptoms, but it is not the same as a mood episode. In someone with possible mania or bipolar symptoms, clinicians may need to determine whether motor restlessness is part of the mood state, a medication effect, or both.
Restless legs syndrome can also cause an urge to move the legs, usually worse at rest and often worse in the evening or at night. It may improve with movement and interfere with sleep. The difference is that akathisia often includes whole-body distress, visible pacing, recent medication exposure, and a more generalized inability to remain still. Still, the two can be difficult to separate, especially when leg discomfort is prominent. A history suggestive of restless legs syndrome may lead clinicians to ask about timing, sensations, iron status, sleep pattern, and medication exposure.
Tardive dyskinesia involves involuntary movements, often of the mouth, tongue, face, trunk, or limbs. Parkinsonism can involve tremor, stiffness, slowed movement, and reduced facial expression. Dystonia involves sustained muscle contractions or abnormal postures. These conditions can occur alongside akathisia because they may share medication-related causes, but their movement patterns are different.
Substance intoxication or withdrawal can produce agitation, tremor, sweating, insomnia, and restlessness. Medical problems such as hyperthyroidism, delirium, pain, infection, medication toxicity, or neurological disease can also change movement and behavior. This is why akathisia is not diagnosed from pacing alone.
The most useful distinction is not “Does the person look restless?” but “What kind of restlessness is this, when did it start, what else changed, and what does the person feel inside?”
Diagnostic Context and Rating Scales
Akathisia is diagnosed clinically, based on symptoms, observed signs, timing, medication exposure, and exclusion of likely alternatives. There is no blood test, brain scan, or single physical finding that confirms it on its own.
A careful evaluation usually starts with the person’s description. Clinicians may ask whether the restlessness feels internal, whether it is relieved by movement, whether sitting still is intolerable, and whether the sensation is new. They may also ask about recent medication starts, dose increases, missed doses, discontinuation, emergency medications, anti-nausea drugs, antidepressants, substances, and supplements.
Observation is also important. During a visit, the clinician may notice pacing, leg swinging, rocking, shifting from foot to foot, repeated standing, or inability to remain seated. However, visible signs can be absent or suppressed. A person may sit still during an appointment out of embarrassment or effort while feeling severe internal distress.
The Barnes Akathisia Rating Scale is one commonly used structured tool. It considers objective restlessness, subjective awareness of restlessness, distress related to restlessness, and global severity. Rating scales do not replace clinical judgment, but they can help document severity and track change over time.
A broader assessment may also review mood symptoms, psychosis symptoms, anxiety, sleep, pain, neurological signs, and substance use. When symptoms are complex, a full mental health evaluation may help separate overlapping conditions and clarify whether the restlessness is part of a psychiatric syndrome, a medication-induced movement disorder, a medical problem, or a combination.
Family members or close observers may provide useful context, especially when the person is distressed or unsure how to describe the change. They may notice that pacing began after a new medication, that the person no longer sits through meals, or that sleep changed abruptly.
Documentation of timing is often one of the most valuable pieces of information. A simple timeline can include the date symptoms started, medication changes in the previous days or weeks, when restlessness is worst, whether movement helps, and whether there are new thoughts of self-harm or impulsive urges. This kind of detail can make the evaluation more accurate.
Importantly, people should not be dismissed because their symptoms sound emotional. Akathisia is a condition in which physical restlessness and mental distress are tightly linked. Taking the subjective experience seriously is central to recognizing it.
Complications and Urgent Evaluation
Akathisia can become dangerous when distress is severe, sleep is disrupted, judgment is impaired, or the person develops suicidal thoughts. Even when it is not dangerous, it can be deeply disabling and should not be minimized.
The most common complications are functional. A person may be unable to sit through work, school, appointments, meals, travel, therapy sessions, or family time. Sleep may become fragmented because lying still feels intolerable. Relationships may become strained if others interpret the restlessness as impatience, anger, noncooperation, or worsening mental illness.
Psychological complications can be serious. Akathisia can cause intense dysphoria, fear, irritability, and desperation. Some people describe feeling trapped or unable to endure the sensation. When this occurs in someone already dealing with depression, psychosis, trauma, substance use, or a recent crisis, the added distress can raise risk.
Medication adherence can also be affected. A person may want to stop the suspected medication abruptly because the sensation feels unbearable. Sudden medication changes can carry risks, depending on the drug and the condition being treated, so new or severe restlessness should be discussed with a qualified clinician promptly rather than handled alone.
Urgent professional evaluation is especially important when akathisia-like symptoms are accompanied by:
- Thoughts of suicide, self-harm, or harming someone else
- New impulsive behavior, severe agitation, or feeling unable to stay safe
- Severe insomnia, confusion, fever, muscle rigidity, or major changes in alertness
- New neurological symptoms such as weakness, fainting, seizure-like episodes, or severe tremor
- Rapid worsening after a medication change
- Restlessness so intense that the person cannot function, sleep, or remain in a safe setting
For symptoms that may require emergency-level assessment, a guide to urgent mental health or neurological symptoms can help clarify when immediate evaluation is appropriate.
Akathisia is not a character flaw, attention-seeking behavior, or ordinary impatience. It is a recognizable clinical syndrome that can be intensely uncomfortable and sometimes high-risk. The safest approach is to treat new, severe, or medication-linked restlessness as medically important, especially when it causes distress that feels out of proportion to the situation.
References
- Akathisia 2023 (Review)
- Extrapyramidal Side Effects 2025 (Review)
- Drug Efficacy in the Treatment of Antipsychotic-Induced Akathisia: A Systematic Review and Network Meta-Analysis 2024 (Systematic Review)
- Antipsychotic-induced akathisia in adults with acute schizophrenia: A systematic review and dose-response meta-analysis 2023 (Systematic Review)
- The Relationship Between Antipsychotic-Induced Akathisia and Suicidal Behaviour: A Systematic Review 2021 (Systematic Review)
- The Assessment and Treatment of Antipsychotic-Induced Akathisia 2018 (Guideline)
Disclaimer
This article is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Akathisia can be severe and may be linked to medication effects or urgent mental health symptoms, so new or worsening restlessness should be evaluated by a qualified healthcare professional.
Thank you for taking the time to read this resource; sharing it may help someone recognize severe medication-related restlessness and seek appropriate support sooner.
